Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury
出版年份 2017 全文链接
标题
Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-04-25
DOI
10.1038/s41598-017-01271-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interferon Tau Affects Mouse Intestinal Microbiota and Expression of IL-17
- (2016) Wenkai Ren et al. MEDIATORS OF INFLAMMATION
- Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development
- (2016) Jian-Ping Liu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Risk of liver injury after α-glucosidase inhibitor therapy in advanced chronic kidney disease patients
- (2016) Chih-Chin Kao et al. Scientific Reports
- Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease
- (2016) David Briskey et al. Therapeutic Advances in Gastroenterology
- Alcoholic Liver Disease: A Mouse Model Reveals Protection by Lactobacillus fermentum
- (2016) Rosario Barone et al. Clinical and Translational Gastroenterology
- Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
- (2016) Céline Pomié et al. Molecular Metabolism
- Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma
- (2016) Haifeng Lu et al. Scientific Reports
- Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology
- (2016) Yanfei Chen et al. Scientific Reports
- Systematic review with meta-analysis:Saccharomyces boulardiiin the prevention of antibiotic-associated diarrhoea
- (2015) H. Szajewska et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Acute liver failure
- (2015) L. Blackmore et al. CLINICAL MEDICINE
- Update on acute liver failure
- (2015) Arjuna Singanayagam et al. Current Opinion in Critical Care
- The gut microbiota and host health: a new clinical frontier
- (2015) Julian R Marchesi et al. GUT
- Gut microbiota and liver diseases
- (2015) Masami Minemura WORLD JOURNAL OF GASTROENTEROLOGY
- Characterising the bacterial microbiota across the gastrointestinal tracts of dairy cattle: membership and potential function
- (2015) Shengyong Mao et al. Scientific Reports
- FXR antagonism of NSAIDs contributes to drug-induced liver injury identified by systems pharmacology approach
- (2015) Weiqiang Lu et al. Scientific Reports
- Saccharomyces boulardii prevention of the hepatic injury induced by Salmonella Enteritidis infection
- (2014) Daichao Wu et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Oral Administration of Saccharomyces boulardii Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Reducing Intestinal Permeability and Modulating Gut Microbial Composition
- (2014) Ming Li et al. INFLAMMATION
- Gut microbiota and liver disease
- (2014) Amit Goel et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- Hepatic inflammation and progressive liver fibrosis in chronic liver disease
- (2014) Albert J Czaja WORLD JOURNAL OF GASTROENTEROLOGY
- Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice
- (2014) A. Everard et al. mBio
- The gut-liver axis
- (2013) Ruben G.J. Visschers et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Intestinal microbiota in patients with nonalcoholic fatty liver disease
- (2013) Marialena Mouzaki et al. HEPATOLOGY
- Bacterial Community Mapping of the Mouse Gastrointestinal Tract
- (2013) Shenghua Gu et al. PLoS One
- Metagenomic sequencing reveals microbiota and its functional potential associated with periodontal disease
- (2013) Jinfeng Wang et al. Scientific Reports
- Bacterial infections in end-stage liver disease: current challenges and future directions
- (2012) Jasmohan S Bajaj et al. GUT
- Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
- (2012) Tiphaine Le Roy et al. GUT
- Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics
- (2012) F. C. P. Tiago et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways
- (2012) Barbara D. Pachikian et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease
- (2012) D. Compare et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Cytokines and STATs in Liver Fibrosis
- (2012) Xiaoni Kong et al. Frontiers in Physiology
- UCHIME improves sensitivity and speed of chimera detection
- (2011) Robert C. Edgar et al. BIOINFORMATICS
- Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms
- (2011) Anna Iacono et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Acute liver failure
- (2010) William Bernal et al. LANCET
- A human gut microbial gene catalogue established by metagenomic sequencing
- (2010) Junjie Qin et al. NATURE
- Systematic review and meta-analysis ofSaccharomyces boulardiiin adult patients
- (2010) Lynne V McFarland WORLD JOURNAL OF GASTROENTEROLOGY
- VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice
- (2009) Arumugam Velayudham et al. HEPATOLOGY
- Management of acute liver failure
- (2009) R. Todd Stravitz et al. Nature Reviews Gastroenterology & Hepatology
- Are animal models predictive for humans?
- (2009) Niall Shanks et al. Philosophy Ethics and Humanities in Medicine
- Acute liver failure related to hepatitis B virus
- (2008) Han Chu Lee HEPATOLOGY RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started